The Prescription Only Medicines (Human Use) Amendment (No. 3) Order 2000
Citation, commencement and interpretation1.
(1)
This Order may be cited as the Prescription Only Medicines (Human Use) Amendment (No. 3) Order 2000 and shall come into force on 1st January 2001.
(2)
Amendment of Schedule 1 to the principal Order2.
In Schedule 1 to the principal Order (which specifies substances which, if included in medicinal products, make those products prescription only medicines, and exemptions from the restrictions on the sale and supply of prescription only medicines), in relation to the substance Levonorgestrel, there are inserted the following entries—
- in column 2—
“0.75mg”; and
- in column 3—
“for use as an emergency contraceptive in women aged 16 years and over”.
This Order amends Schedule 1 to the Prescription Only Medicines (Human Use) Order 1997 (which specifies substances which, if included in medicinal products, make them prescription only medicines, and exemptions from the restrictions in section 58(2) on sale and supply of prescription only medicines) to provide that medicinal products consisting of or containing Levonorgestrel may be sold or supplied otherwise than as a prescription only medicine provided that they are at a maximum strength of 0.75 mg and are sold or supplied exclusively for use as an emergency contraceptive in women aged 16 years and over.
An assessment to the cost to business of complying with this Order has been made, copies of which have been placed in the libraries of both Houses of Parliament. Further copies may be obtained from the Department of Health, Medicines Control Agency, Information Centre, Room 10-202 Market Towers, 1 Nine Elms Lane, London SW8 5NQ.